NCT02628405 2024-07-01R-ICE and Lenalidomide in Treating Patients With First-Relapse/Primary Refractory Diffuse Large B-Cell LymphomaAcademic and Community Cancer Research UnitedPhase 1/2 Active not recruiting30 enrolled 15 charts
NCT03064867 2022-11-16Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell LymphomaCase Comprehensive Cancer CenterPhase 1/2 Active not recruiting65 enrolled